Subscribe

Prenetics Global Limited (PRE)

USD18.35 -2.89 (-13.61%)
HK NASDAQ Healthcare Medical - Diagnostics & Research
Address Unit 701-706, K11 Atelier King’s Road
Quarry Bay, HK
CEO Sheng Wu Yeung
IPO 2021-07-16
CIK 1876431 ISIN KYG722451229

Explore sections of this company profile

Also trades on NASDAQ Global Market · PRE (USD) NASDAQ Global Market · PRENW (USD) New York Stock Exchange · PRE-PJ (USD)
Description

As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.

News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD18.35 -2.89 (-13.61%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
210.5K
Beta
0.24
Float Shares
14.42M
Free Float %
84.8%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+4.54% +7.19% +23.11% +4.39% +45.56% +37.33% +208.56% +63.86% -81.02% -81.02% -81.02%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Buy
Price Targets & DCF
Current price
18.35
Low 36.00 +96.2%
Consensus 36.00 +96.2%
Median 36.00 +96.2%
High 36.00 +96.2%
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 2 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year 1
36.00
+96.2%
All Time 1
36.00
+96.2%
Quality scores
Altman Z-Score
4.44
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Diagnostics & Research: +7.9%
    +201.7% Q1'26: +107.7% (vs Q1'25)
  • EPS growth Medical - Diagnostics & Research: +30.8%
    +26.4% Q1'26: -70.0% (vs Q1'25)
  • FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%
    -28.2% Q1'26: -33.7% (vs Q1'25)
  • EBIT margin Medical - Diagnostics & Research: +9.6%
    -38.9% Q1'26: -27.0% (vs Q1'25)
  • ROIC Medical - Diagnostics & Research: +5.2%
    -31.2% Q1'26: -251.4% (vs Q1'25)
  • Share dilution Medical - Diagnostics & Research: 0.0%
    +10.6% Q1'26: +30.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×
    -0.07× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.24) × ERP
WACC = 99% × Ke + 1% × Kd (10.9%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 18.35
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
3 Rev. Ana.
2 EPS Ana.
Dec 2027
3 Rev. Ana.
2 EPS Ana.
Revenue
13.16M
est: 289.15M (-95.4%)
21.74M
est: 22.66M (-4.1%)
30.62M
est: 32.60M (-6.1%)
92.39M
est: 90.14M (+2.5%)
198.69M
194.12M – 201.97M
+120.4% YoY
306.57M
295.61M – 324.93M
+54.3% YoY
EBITDA
-218.04M
est: -232.57M (+6.3%)
-47.90M
est: -19.71M (-143.0%)
-51.57M
est: -28.35M (-81.9%)
-32.19M
est: -78.40M (+58.9%)
-172.80M
-175.65M – -168.82M
-120.4% YoY
-266.62M
-282.59M – -257.09M
-54.3% YoY
EBIT
-225.58M
est: -234.73M (+3.9%)
-55.69M
est: -19.89M (-179.9%)
-57.50M
est: -28.62M (-100.9%)
-35.97M
est: -79.14M (+54.5%)
-174.42M
-177.30M – -170.41M
-120.4% YoY
-269.13M
-285.25M – -259.51M
-54.3% YoY
Net Income
-190.45M
est: -419.11M (+54.6%)
-62.72M
est: -49.93M (-25.6%)
-46.30M
est: -46.71M (+0.9%)
-37.71M
est: -33.98M (-11.0%)
-47.46M
-50.12M – -44.79M
-39.7% YoY
-7.11M
-7.51M – -6.71M
+85.0% YoY
SGA
64.08M
est: 786.36M (-91.9%)
49.68M
est: 63.94M (-22.3%)
55.37M
est: 91.98M (-39.8%)
79.80M
est: 254.34M (-68.6%)
560.58M
547.69M – 569.84M
+120.4% YoY
864.97M
834.04M – 916.76M
+54.3% YoY
EPS
-37.57
est: -32.99 (-13.9%)
-5.58
est: -3.53 (-58.2%)
-3.64
est: -3.30 (-10.3%)
-2.68
est: -2.52 (-6.5%)
-3.35
-3.57 – -3.19
-33.2% YoY
-0.50
-0.53 – -0.48
+85.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-06-12 C 2/5 1/5 1/5 1/5 4/5 1/5 2/5
2026-06-11 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-10 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-09 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-08 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-05 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-04 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-03 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-02 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-06-01 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-28 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-27 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-26 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-22 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-21 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-20 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-19 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-18 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-15 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-14 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-13 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-12 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-11 C+ 2/5 1/5 1/5 1/5 4/5 1/5 4/5
2026-05-08 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-05-07 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-05-06 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-05-05 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-05-04 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-05-01 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-04-30 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-04-29 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-04-28 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-04-27 C 2/5 1/5 1/5 1/5 3/5 1/5 4/5
2026-04-24 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-23 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-22 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-21 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-20 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-17 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-04-16 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-10.82M
OE per share TTM
-0.58
Owner's Yield
-2.95%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
19.7%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
35
Total invested
38.46M
Insider transactions (90d)
2
Beneficial owners (>5%)
18
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Lo Yuk Ming Dennis 14.44M 9.16% 14.44M 14.44M IN 2023-08-07
2 Artisan LLC 12.79M 11.94% 12.79M 12.79M OO Hong Kong 2022-05-31
3 Woodbury Capital Management Limited 11.19M 10.52% 11.19M 11.19M OO British Virgin Islands 2022-06-29
4 Da Yeung Limited 9.71M 8.75% 9.71M 9.71M 10.00 CO British Virgin Islands 2022-05-31
5 Yeung Danny Sheng Wu 9.71M 8.75% 9.71M 9.71M 10.00 IN Hong Kong SAR 2022-05-31
6 Genetel Bioventures Limited 9.21M 9.10% 9.21M 9.21M OO Hong Kong SAR 2022-08-17
7 Michael Yang Mengsu 9.21M 9.10% 9.21M 9.21M IN Hong Kong SAR 2022-08-17
8 Tzang Chi Hung Lawrence 8.04M 5.06% 8.04M 8.04M IN 2023-03-27
9 Aspex Management (HK) Limited 6.70M 6.52% 6.70M 6.70M HC, OO Hong Kong 2022-05-27
10 Aspex Master Fund 6.70M 6.52% 6.70M 6.70M HC, OO Hong Kong 2022-05-27
11 LI Ho Kei 6.70M 6.52% 6.70M 6.70M HC, IN Hong Kong 2022-05-27
12 PAG 5.60M 5.50% 5.60M 5.60M CO Cayman Islands 2022-05-31
13 Pacific Alliance Group Limited 5.60M 5.50% 5.60M 5.60M CO Cayman Islands 2022-05-31
14 Pacific Alliance INVESTMENT MANAGEMENT LIMITED 5.53M 5.40% 5.53M 5.53M CO Cayman Islands 2022-05-31
15 PAG Quantitative Strategies Trading Limited 5.52M 5.40% 5.52M 5.52M CO Cayman Islands 2022-05-31
16 Pacific Alliance Asia Opportunity Fund L.P. 5.52M 5.40% 5.52M 5.52M PN Cayman Islands 2022-05-31
17 Pacific Alliance GROUP ASSET MANAGEMENT LIMITED 5.52M 5.40% 5.52M 5.52M CO Cayman Islands 2022-05-31
18 For Excelsiors Limited 3.84M 2.42% 3.84M 3.84M CO 2023-03-27

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
35
-1 vs prev Q
New positions
12
Closed positions
13
Increased
22
Reduced
8
Put/Call ratio
0.00
Calls held
24.9K
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 PRUDENTIAL PLC 428.0K +— (+0.0%) 6.74M +1.0M (+18.4%) 2.67% -0.411 pp 0.05% +0.012 pp USD5.91 +166.5% 9 qtrs
2 ASPEX MANAGEMENT (HK) LTD 346.2K +— (+0.0%) 5.45M +848.0K (+18.4%) 2.16% -0.332 pp 0.11% +0.013 pp USD4.22 +273.2% 8 qtrs
3 NOMURA HOLDINGS INC 268.0K -49.0K (-15.5%) 4.22M +4.9K (+0.1%) 1.67% -0.610 pp 0.01% -0.001 pp USD5.19 +203.5% 9 qtrs
4 JANE STREET GROUP, LLC 82.7K +82.7K (+100.0%) 1.30M +1.3M (+100.0%) 0.52% +0.516 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
5 683 CAPITAL MANAGEMENT, LLC 75.0K +75.0K (+100.0%) 1.18M +1.2M (+100.0%) 0.47% +0.468 pp 0.05% +0.051 pp USD15.75 +0.0% 1 qtrs NEW
6 SUSQUEHANNA INTERNATIONAL GROUP, LLP 54.8K +54.8K (+100.0%) 863.1K +863.1K (+100.0%) 0.34% +0.342 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
7 MILLENNIUM MANAGEMENT LLC 51.4K +51.4K (+100.0%) 810.1K +810.1K (+100.0%) 0.32% +0.321 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
8 MARSHALL WACE, LLP 50.0K +50.0K (+100.0%) 787.9K +787.9K (+100.0%) 0.31% +0.312 pp 0.00% +0.001 pp USD15.75 +0.0% 1 qtrs NEW
9 GOLDMAN SACHS GROUP INC 42.2K +42.2K (+100.0%) 665.4K +665.4K (+100.0%) 0.26% +0.264 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
10 QUBE RESEARCH & TECHNOLOGIES LTD 31.1K +31.1K (+100.0%) 490.5K +490.5K (+100.0%) 0.19% +0.194 pp 0.00% +0.001 pp USD15.75 +0.0% 1 qtrs NEW
11 BLACKROCK, INC. 31.1K +7.8K (+33.5%) 489.5K +179.8K (+58.0%) 0.19% +0.026 pp 0.00% +0.000 pp USD10.33 +52.5% 3 qtrs
12 FIFTH LANE CAPITAL, LP 30.0K +30.0K (+100.0%) 472.5K +472.5K (+100.0%) 0.19% +0.187 pp 0.36% +0.358 pp USD15.75 +0.0% 1 qtrs NEW
13 ACADIAN ASSET MANAGEMENT LLC 30.1K +28.2K (+1,434.8%) 471.0K +445.0K (+1,711.5%) 0.19% +0.174 pp 0.00% +0.001 pp USD15.59 +1.0% 2 qtrs
14 QUADRATURE CAPITAL LTD 29.7K +29.7K (+100.0%) 467.8K +467.8K (+100.0%) 0.19% +0.185 pp 0.00% +0.005 pp USD15.75 +0.0% 1 qtrs NEW
15 POINT72 ASSET MANAGEMENT, L.P. 27.3K +27.3K (+100.0%) 430.0K +430.0K (+100.0%) 0.17% +0.170 pp 0.00% +0.001 pp USD15.75 +0.0% 1 qtrs NEW
16 MORGAN STANLEY 23.8K +14.0K (+142.3%) 374.8K +244.2K (+186.9%) 0.15% +0.078 pp 0.00% +0.000 pp USD12.54 +25.6% 6 qtrs
17 OMERS ADMINISTRATION CORP 19.5K +19.5K (+100.0%) 307.1K +307.1K (+100.0%) 0.12% +0.122 pp 0.00% +0.002 pp USD15.75 +0.0% 1 qtrs NEW
18 HUDSON BAY CAPITAL MANAGEMENT LP 18.8K +18.8K (+100.0%) 295.7K +295.7K (+100.0%) 0.12% +0.117 pp 0.00% +0.001 pp USD15.75 +0.0% 1 qtrs NEW
19 STEVENS CAPITAL PARTNERS 18.2K +825.0 (+4.7%) 286.8K +55.6K (+24.0%) 0.11% -0.012 pp 0.08% +0.006 pp USD8.85 +78.0% 3 qtrs
20 BNP PARIBAS ARBITRAGE, SNC 17.8K +17.8K (+100.0%) 280.8K +280.8K (+100.0%) 0.11% +0.111 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
21 JUMP FINANCIAL, LLC 17.0K +17.0K (+100.0%) 267.8K +267.8K (+100.0%) 0.11% +0.106 pp 0.00% +0.003 pp USD15.75 +0.0% 1 qtrs NEW
22 RENAISSANCE TECHNOLOGIES LLC 16.9K -9.3K (-35.5%) 266.5K -82.2K (-23.6%) 0.11% -0.083 pp 0.00% +0.000 pp USD13.30 +18.4% 2 qtrs
23 BOOTHBAY FUND MANAGEMENT, LLC 15.3K +15.3K (+100.0%) 241.5K +241.5K (+100.0%) 0.10% +0.096 pp 0.00% +0.004 pp USD15.75 +0.0% 1 qtrs NEW
24 SEI INVESTMENTS CO 11.9K +11.9K (+100.0%) 188.0K +188.0K (+100.0%) 0.07% +0.074 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
25 KINGSVIEW WEALTH MANAGEMENT, LLC 10.9K +10.9K (+100.0%) 171.5K +171.5K (+100.0%) 0.07% +0.068 pp 0.00% +0.003 pp USD15.75 +0.0% 1 qtrs NEW
26 10.8K +10.8K (+100.0%) 170.1K +170.1K (+100.0%) 0.07% +0.067 pp 0.21% +0.211 pp USD15.75 +0.0% 1 qtrs NEW
27 MANATUCK HILL PARTNERS, LLC 10.8K +10.8K (+100.0%) 170.1K +170.1K (+100.0%) 0.07% +0.067 pp 0.06% +0.060 pp USD15.75 +0.0% 1 qtrs NEW
28 CITADEL ADVISORS LLC 10.1K +10.1K (+100.0%) 159.1K +159.1K (+100.0%) 0.06% +0.063 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
29 UBS GROUP AG 9.0K -37.5K (-80.6%) 141.9K -477.3K (-77.1%) 0.06% -0.279 pp 0.00% 0.000 pp USD12.18 +29.3% 8 qtrs
30 JPMORGAN CHASE & CO 8.4K +3.5K (+72.1%) 132.8K +67.7K (+103.8%) 0.05% +0.017 pp 0.00% +0.000 pp USD14.33 +9.9% 2 qtrs
31 CITIGROUP INC 4.9K +4.9K (+100.0%) 76.9K +76.9K (+100.0%) 0.03% +0.031 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
32 WELLS FARGO & COMPANY/MN 3.0K +3.0K (+100.0%) 47.3K +47.3K (+100.0%) 0.02% +0.019 pp 0.00% +0.000 pp USD15.75 +0.0% 1 qtrs NEW
33 CORECAP ADVISORS, LLC 25.00 +— (+0.0%) 394.00 +61.0 (+18.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD8.52 +84.9% 3 qtrs
34 WOLVERINE ASSET MANAGEMENT LLC 1.00 +— (+0.0%) 16.00 +3.0 (+23.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD5.00 +215.0% 9 qtrs
35 SBI SECURITIES CO., LTD. 1.00 -2.0 (-66.7%) 16.00 -24.0 (-60.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD10.00 +57.5% 5 qtrs
36 ABRDN PLC -73.6K (-100.0%) -979.2K (-100.0%) 0.00% -0.530 pp 0.00% -0.002 pp USD 2 qtrs SOLD
37 BANK OF AMERICA CORP /DE/ -10.0 (-100.0%) -133.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 9 qtrs SOLD
38 FNY INVESTMENT ADVISERS, LLC -1.1K (-100.0%) -14.0K (-100.0%) 0.00% -0.008 pp 0.00% -0.005 pp USD 2 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 3 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P International Small Cap ETF GWX 0.02% 137.4K 0.40%
2 State Street SPDR S&P Emerging Markets Small Cap ETF EWX 0.02% 110.2K 0.65%
3 State Street SPDR Portfolio Emerging Markets ETF SPEM 0.01% 1.15M 0.07%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
98.0K
Shares disposed
Cash buys
Cash sales
Net activity
+98,035
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-26 Cheng Yin Pan Director A-Award A Restricted Stock Unit 6,406 0.00 22,279 I
2026-05-19 Lo Hoi Chun Officer A-Award A Restricted Stock Unit 91,629 0.00 597,930 D
2026-03-26 Yeung Danny Sheng Wu Director / Officer Class B Ordinary Share, par value $0.0015 per share 0 0.00 933,380 D
2026-03-26 Shah Darshan Ravindra Director Class A Ordinary Share, par value $0.0015 per share 0 0.00 4,506 D
2026-03-24 Cheng Yin Pan Director Class A Ordinary Share, par value $0.0015 per share 0 0.00 43,178 I
2026-03-18 VANDERVEEN DAVID Director Restricted Stock Unit 8,681 0.00 0 D
2026-03-18 Lo Hoi Chun Officer Restricted Stock Unit 15,272 0.00 0 D
2022-06-17 Cheng Yin Pan Director Warrant 48,816 133.65 6.52M 0 I
2016-03-18 ZWIENER DAVID K Director / Officer D-Return D Non-qualified Stock Option (Right to Buy) 8,170 75.54 617.2K 0
2016-03-18 Walker Theodore C Officer A-Award A Common Shares 2,315 0.00 39,936
2016-03-18 Seow Greg Fook-Hin Director D-Return D Common Shares 4,587 137.50 630.7K 0
2016-03-18 SAUTTER REMY Director D-Return D Restricted Share Units 1,458 0.00 0
2016-03-18 PERRY DEBRA J Director D-Return D Common Shares 4,204 137.50 578.1K 0
2016-03-18 Outtrim David Officer A-Award A Common Shares 565 0.00 11,619
2016-03-18 MONTUPET JEAN PAUL L Director D-Return D Non-qualified Stock Option (Right to Buy) 4,459 68.59 305.8K 0
2016-03-18 MENDOZA ROBERTO G Director D-Return D Non-qualified Stock Option (Right to Buy) 5,719 75.54 432.0K 0
2016-03-18 Desmet Laurie Officer D-Return D Stock Appreciation Rights 2,763 61.90 171.0K 0
2016-03-18 Clarke Emmanuel Officer D-Return D Stock Appreciation Rights 2,763 61.90 171.0K 0
2016-03-01 Walker Theodore C Officer F-InKind D Common Shares 2,744 140.35 385.1K 34,818
2016-03-01 Outtrim David Officer A-Award A Common Shares 569 0.00 10,584
2016-03-01 Desmet Laurie Officer F-InKind D Common Shares 1,059 140.35 148.6K 38,308
2016-03-01 Clarke Emmanuel Officer F-InKind D Common Shares 472 140.35 66.2K 57,266
2015-12-21 Desmet Laurie Officer S-Sale D Common Shares 710 139.11 98.8K 38,386
2015-09-17 SAUTTER REMY Director S-Sale D Common Shares 100 138.51 13.9K 19,684
2015-09-16 SAUTTER REMY Director S-Sale D Common Shares 379 138.47 52.5K 19,884
2015-06-15 ZWIENER DAVID K Director / Officer M-Exempt D Restricted Share Units 978 0.00 0
2015-06-15 Seow Greg Fook-Hin Director A-Award A Common Shares 1,533 0.00 4,587
2015-06-15 SAUTTER REMY Director M-Exempt D Restricted Share Units 391 0.00 0
2015-06-15 PERRY DEBRA J Director A-Award A Common Shares 1,150 0.00 4,204
2015-06-15 MONTUPET JEAN PAUL L Director M-Exempt D Restricted Share Units 455 0.00 0
2015-06-15 MENDOZA ROBERTO G Director M-Exempt D Restricted Share Units 1,297 0.00 0
2015-05-29 Walker Theodore C Officer A-Award A Common Shares 234 90.50 21.2K 40,637
2015-05-29 Outtrim David Officer A-Award A Common Shares 159 90.50 14.4K 10,015
2015-05-29 Desmet Laurie Officer A-Award A Common Shares 150 90.50 13.6K 39,096
2015-05-29 Clarke Emmanuel Officer A-Award A Common Shares 234 90.50 21.2K 55,185
2015-03-02 Walker Theodore C Officer F-InKind D Common Shares 1,849 114.61 211.9K 40,403
2015-03-02 Desmet Laurie Officer F-InKind D Common Shares 440 114.61 50.4K 38,946
2015-03-02 Clarke Emmanuel Officer F-InKind D Common Shares 196 114.61 22.5K 54,951
2015-02-17 Walker Theodore C Officer A-Award A Stock Appreciation Rights 16,204 118.80 1.93M 16,204
2015-02-17 Outtrim David Officer A-Award A Common Shares 1,108 0.00 8,916
2015-02-17 Desmet Laurie Officer A-Award A Common Shares 4,630 0.00 39,386
2015-02-17 Clarke Emmanuel Officer A-Award A Stock Appreciation Rights 16,204 118.80 1.93M 16,204
2015-02-05 Walker Theodore C Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 29 62.70 1.8K 3,344
2015-02-05 Desmet Laurie Officer M-Exempt A Common Shares 704 0.00 30,126
2015-02-04 Clarke Emmanuel Officer M-Exempt A Common Shares 3,991 0.00 45,887
2015-01-26 ZWIENER DAVID K Director / Officer A-Award A Common Shares 12,987 0.00 23,025
2015-01-26 MONTUPET JEAN PAUL L Director A-Award A Common Shares 866 0.00 16,372
2015-01-26 MENDOZA ROBERTO G Director A-Award A Common Shares 866 0.00 7,511
2015-01-21 Desmet Laurie Officer F-InKind D Common Shares 709 113.76 80.7K 29,422
2014-12-04 Clarke Emmanuel Officer M-Exempt A Common Shares 2,495 0.00 41,896
2014-11-28 Outtrim David Officer A-Award A Common Shares 77 90.50 7.0K 7,808
2014-11-28 Desmet Laurie Officer A-Award A Common Shares 86 90.50 7.8K 30,131
2014-11-28 Clarke Emmanuel Officer A-Award A Common Shares 2 90.50 181.00 39,401
2014-11-07 Clarke Emmanuel Officer M-Exempt D Stock Appreciation Rights 2,000 61.20 122.4K 5,500
2014-10-31 Clarke Emmanuel Officer M-Exempt A Common Shares 2,000 63.96 127.9K 41,002
2014-10-23 Clarke Emmanuel Officer S-Sale D Common Shares 500 115.00 57.5K 39,002
2014-09-02 Clarke Emmanuel Officer S-Sale D Common Shares 500 113.00 56.5K 39,502
2014-08-25 SAUTTER REMY Director M-Exempt A Common Shares 5,549 73.19 406.1K 22,630
2014-08-25 Clarke Emmanuel Officer S-Sale D Common Shares 500 111.00 55.5K 40,002
2014-08-21 SAUTTER REMY Director S-Sale D Common Shares 1,719 110.26 189.5K 17,081
2014-08-20 MONTUPET JEAN PAUL L Director M-Exempt A Common Shares 9,000 68.59 617.3K 24,506
2014-06-27 Walker Theodore C Officer S-Sale D Common Shares 100 108.36 10.8K 29,152
2014-06-16 ZWIENER DAVID K Director A-Award A Common Shares 1,401 0.00 10,038
2014-06-16 Seow Greg Fook-Hin Director A-Award A Common Shares 1,868 0.00 3,054
2014-06-16 SAUTTER REMY Director A-Award A Common Shares 2,335 0.00 17,081
2014-06-16 PERRY DEBRA J Director A-Award A Common Shares 1,868 0.00 3,054
2014-06-16 MONTUPET JEAN PAUL L Director A-Award A Common Shares 1,681 0.00 15,506
2014-06-16 MENDOZA ROBERTO G Director A-Award A Common Shares 1,401 0.00 6,645
2014-06-06 Clarke Emmanuel Officer S-Sale D Common Shares 150 109.12 16.4K 40,502
2014-06-05 Outtrim David Officer S-Sale D Common Shares 300 108.21 32.5K 8,731
2014-06-05 Clarke Emmanuel Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 500 62.70 31.4K 0
2014-05-30 Walker Theodore C Officer A-Award A Common Shares 278 76.32 21.2K 32,473
2014-05-30 Outtrim David Officer A-Award A Common Shares 185 76.32 14.1K 9,625
2014-05-30 Desmet Laurie Officer A-Award A Common Shares 175 76.32 13.4K 30,045
2014-05-30 Clarke Emmanuel Officer A-Award A Common Shares 274 76.32 20.9K 40,565
2014-05-23 Clarke Emmanuel Officer M-Exempt A Common Shares 500 62.70 31.4K 40,791
2014-05-02 Clarke Emmanuel Officer M-Exempt A Common Shares 500 62.70 31.4K 40,791
2014-04-29 Clarke Emmanuel Officer S-Sale D Common Shares 200 106.63 21.3K 40,291
2014-02-28 Walker Theodore C Officer A-Award A Stock Appreciation Rights 19,468 98.88 1.92M 19,468
2014-02-28 Pestcoe Marvin Officer A-Award A Common Shares 5,562 0.00 39,089
2014-02-28 Outtrim David Officer A-Award A Common Shares 1,129 0.00 7,805
2014-02-28 Desmet Laurie Officer A-Award A Stock Appreciation Rights 19,468 98.88 1.92M 19,468
2014-02-28 Clarke Emmanuel Officer A-Award A Stock Appreciation Rights 19,468 98.88 1.92M 19,468
2014-02-18 Walker Theodore C Officer F-InKind D Common Shares 3,152 101.24 319.1K 21,071
2014-02-18 Pestcoe Marvin Officer F-InKind D Common Shares 2,040 101.24 206.5K 33,527
2014-02-18 Desmet Laurie Officer F-InKind D Common Shares 779 101.24 78.9K 18,746
2014-02-18 Clarke Emmanuel Officer F-InKind D Common Shares 316 101.24 32.0K 29,167
2013-12-31 Clarke Emmanuel Officer S-Sale D Common Shares 300 105.90 31.8K 29,483
2013-12-30 Clarke Emmanuel Officer S-Sale D Common Shares 150 105.00 15.8K 29,483
2013-11-29 Outtrim David Officer A-Award A Common Shares 59 76.32 4.5K 6,676
2013-11-29 Desmet Laurie Officer A-Award A Common Shares 106 76.32 8.1K 19,525
2013-11-29 Clarke Emmanuel Officer A-Award A Common Shares 11 76.32 839.54 29,633
2013-10-29 Walker Theodore C Officer S-Sale D Common Shares 200 99.52 19.9K 26,734
2013-10-29 Clarke Emmanuel Officer S-Sale D Common Shares 750 98.00 73.5K 29,622
2013-09-20 Outtrim David Officer S-Sale D Common Shares 400 90.98 36.4K 7,991
2013-08-23 Walker Theodore C Officer S-Sale D Common Shares 7,556 89.00 672.5K 24,223
2013-07-02 Desmet Laurie Officer D Stock Appreciation Rights 10,000 75.67 756.7K 0
2013-06-17 ZWIENER DAVID K Director A-Award A Common Shares 1,643 0.00 8,637
2013-06-17 Seow Greg Fook-Hin Director A-Award A Common Shares 1,186 0.00 1,186
2013-06-17 SAUTTER REMY Director A-Award A Common Shares 2,190 0.00 14,746
2013-06-17 PERRY DEBRA J Director A-Award A Common Shares 1,186 0.00 1,186
2013-06-17 MONTUPET JEAN PAUL L Director A-Award A Common Shares 1,971 0.00 13,825
2013-06-17 MENDOZA ROBERTO G Director A-Award A Common Shares 1,643 0.00 5,244
2013-06-15 Seow Greg Fook-Hin Director D Common Shares 0 0.00 0
2013-06-15 PERRY DEBRA J Director D Common Shares 0 0.00 0
2013-05-31 Walker Theodore C Officer A-Award A Common Shares 349 60.80 21.2K 31,779
2013-05-31 Pestcoe Marvin Officer A-Award A Common Shares 349 60.80 21.2K 35,567
2013-05-31 Outtrim David Officer A-Award A Common Shares 274 60.80 16.7K 8,391
2013-05-31 Desmet Laurie Officer A-Award A Common Shares 215 60.80 13.1K 19,419
2013-05-31 Clarke Emmanuel Officer A-Award A Common Shares 334 60.80 20.3K 30,278
2013-05-17 BAUMGARTNER VITO H Director M-Exempt A Common Shares 2,370 89.38 211.8K 18,000
2013-04-26 Clarke Emmanuel Officer M-Exempt A Common Shares 2,000 55.63 111.3K 31,944
2013-04-01 Desmet Laurie Officer D Stock Appreciation Rights 10,000 70.70 707.0K 0
2013-03-19 SAUTTER REMY Director M-Exempt A Common Shares 5,131 59.43 304.9K 17,687
2013-03-05 MONTUPET JEAN PAUL L Director S-Sale D Common Shares 100 90.34 9.0K 11,854
2013-03-01 Walker Theodore C Officer A-Award A Common Shares 5,605 0.00 31,430
2013-03-01 Pestcoe Marvin Officer A-Award A Common Shares 5,605 0.00 29,613
2013-03-01 Outtrim David Officer A-Award A Common Shares 1,699 0.00 6,979
2013-03-01 Desmet Laurie Officer D Stock Appreciation Rights 7,500 63.44 475.8K 0
2013-03-01 Clarke Emmanuel Officer A-Award A Stock Appreciation Rights 19,619 89.20 1.75M 19,619
2013-02-27 Outtrim David Officer S-Sale D Common Shares 200 88.48 17.7K 7,480
2013-02-26 Walker Theodore C Officer F-InKind D Common Shares 3,092 88.27 272.9K 20,220
2013-02-26 Pestcoe Marvin Officer F-InKind D Common Shares 508 88.27 44.8K 24,008
2013-02-26 Clarke Emmanuel Officer F-InKind D Common Shares 82 88.27 7.2K 18,734
2013-02-25 Pestcoe Marvin Officer M-Exempt A Common Shares 3,347 62.70 209.9K 24,516
2013-01-22 SAUTTER REMY Director M-Exempt D Non-qualified Stock Option (Right to Buy) 4,500 54.76 246.4K 0
2012-12-28 ROLLWAGEN JOHN A Director G-Gift D Restricted Share Units 1,458 0.00 0
2012-12-24 Walker Theodore C Officer S-Sale D Common Shares 331 81.05 26.8K 23,612
2012-12-24 ROLLWAGEN JOHN A Director M-Exempt D Non-qualified Stock Option (Right to Buy) 500 54.08 27.0K 0
2012-12-21 SAUTTER REMY Director S-Sale D Common Shares 100 80.63 8.1K 14,956
2012-12-21 ROLLWAGEN JOHN A Director S-Sale D Common Shares 100 80.90 8.1K 13,116
2012-12-04 ROLLWAGEN JOHN A Director S-Sale D Common Shares 977 80.74 78.9K 13,116
2012-11-30 Walker Theodore C Officer A-Award A Common Shares 1 60.80 60.80 30,002
2012-11-30 Outtrim David Officer A-Award A Common Shares 81 60.80 4.9K 8,894
2012-11-30 Clarke Emmanuel Officer A-Award A Common Shares 10 60.80 608.01 18,816
2012-10-18 Clarke Emmanuel Officer M-Exempt A Common Shares 1,000 55.63 55.6K 19,806
2012-10-16 Clarke Emmanuel Officer M-Exempt A Common Shares 1,000 55.63 55.6K 19,806
2012-10-11 Clarke Emmanuel Officer M-Exempt A Common Shares 1,000 55.63 55.6K 19,806
2012-09-18 Clarke Emmanuel Officer M-Exempt A Common Shares 1,000 49.68 49.7K 19,806
2012-09-13 Clarke Emmanuel Officer M-Exempt A Common Shares 1,000 49.68 49.7K 19,806
2012-09-07 Clarke Emmanuel Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 1,000 49.68 49.7K 2,000
2012-09-05 ROLLWAGEN JOHN A Director S-Sale D Common Shares 1,120 74.79 83.8K 14,093
2012-08-02 Pestcoe Marvin Officer M-Exempt D Non-qualified Stock Option (Right to Buy) 4,717 55.63 262.4K 2,283
2012-06-15 ZWIENER DAVID K Director A-Award A Non-qualified Stock Option (Right to Buy) 10,127 71.12 720.2K 10,127
2012-06-15 SAUTTER REMY Director A-Award A Non-qualified Stock Option (Right to Buy) 10,127 71.12 720.2K 10,127
2012-06-15 ROLLWAGEN JOHN A Director A-Award A Non-qualified Stock Option (Right to Buy) 10,127 71.12 720.2K 10,127
2012-06-15 MONTUPET JEAN PAUL L Director A-Award A Common Shares 1,688 0.00 11,854
2012-06-15 MENDOZA ROBERTO G Director A-Award A Non-qualified Stock Option (Right to Buy) 10,127 71.12 720.2K 10,127
2012-06-15 BAUMGARTNER VITO H Director A-Award A Non-qualified Stock Option (Right to Buy) 10,127 71.12 720.2K 10,127
2012-06-04 ROLLWAGEN JOHN A Director S-Sale D Common Shares 1,062 71.03 75.4K 13,806
2012-05-31 Walker Theodore C Officer A-Award A Common Shares 382 55.38 21.2K 30,001
2012-05-31 Pestcoe Marvin Officer A-Award A Common Shares 383 55.38 21.2K 18,886
2012-05-31 Outtrim David Officer A-Award A Common Shares 293 55.38 16.2K 8,813
2012-05-31 Clarke Emmanuel Officer A-Award A Common Shares 372 55.38 20.6K 18,681
2012-04-18 Walker Theodore C Officer S-Sale D Common Shares 631 67.06 42.3K 29,619
2012-04-17 Walker Theodore C Officer M-Exempt A Common Shares 1,263 48.43 61.2K 30,250
2012-04-16 Walker Theodore C Officer S-Sale D Common Shares 300 66.95 20.1K 32,687
2012-03-02 ROLLWAGEN JOHN A Director S-Sale D Common Shares 1,182 63.86 75.5K 14,868
2012-02-29 Walker Theodore C Officer A-Award A Stock Appreciation Rights 28,500 63.44 1.81M 28,500
2012-02-29 Pestcoe Marvin Officer A-Award A Common Shares 3,800 0.00 18,503
2012-02-29 Outtrim David Officer A-Award A Common Shares 880 0.00 8,520
2012-02-29 Clarke Emmanuel Officer A-Award A Stock Appreciation Rights 28,500 63.44 1.81M 28,500
2012-02-28 Clarke Emmanuel Officer F-InKind D Common Shares 36 64.98 2.3K 14,509
2012-02-27 Walker Theodore C Officer F-InKind D Common Shares 115 64.98 7.5K 25,187
2012-02-27 Pestcoe Marvin Officer F-InKind D Common Shares 184 64.98 12.0K 14,703
2012-02-24 Clarke Emmanuel Officer M-Exempt A Common Shares 341 53.80 18.3K 14,545
2012-02-23 Clarke Emmanuel Officer S-Sale D Common Shares 1,659 64.85 107.6K 14,204
2012-01-16 Outtrim David Officer A-Award A Common Shares 1,250 0.00 7,640
2012-01-05 ROLLWAGEN JOHN A Director S-Sale D Common Shares 100 62.71 6.3K 20,150
2011-12-02 ROLLWAGEN JOHN A Director S-Sale D Common Shares 1,165 65.26 76.0K 16,050
2011-11-30 Outtrim David Officer A-Award A Common Shares 78 55.86 4.4K 6,390
2011-09-08 ROLLWAGEN JOHN A Director S-Sale D Common Shares 1,262 57.30 72.3K 17,215
2011-06-16 ZWIENER DAVID K Director P-Purchase A Common Shares 200 69.17 13.8K 5,187
2011-06-15 ZWIENER DAVID K Director A-Award A Restricted Share Units 1,458 0.00 1,458
2011-06-15 SAUTTER REMY Director A-Award A Restricted Share Units 1,458 0.00 1,458
2011-06-15 ROLLWAGEN JOHN A Director A-Award A Restricted Share Units 1,458 0.00 1,458
2011-06-15 MONTUPET JEAN PAUL L Director A-Award A Restricted Share Units 1,750 0.00 1,750
2011-06-15 MENDOZA ROBERTO G Director A-Award A Restricted Share Units 1,458 0.00 1,458
2011-06-15 BAUMGARTNER VITO H Director A-Award A Restricted Share Units 2,370 0.00 2,370
2011-06-02 ROLLWAGEN JOHN A Director S-Sale D Common Shares 1,341 73.69 98.8K 18,477
2011-05-31 Walker Theodore C Officer A-Award A Common Shares 349 60.73 21.2K 25,302
2011-05-31 Pestcoe Marvin Officer A-Award A Common Shares 349 60.73 21.2K 14,887
2011-05-31 Outtrim David Officer A-Award A Common Shares 262 60.73 15.9K 6,312
2011-05-31 Clarke Emmanuel Officer A-Award A Common Shares 126 44.90 5.7K 14,204
2011-03-02 ROLLWAGEN JOHN A Director S-Sale D Common Shares 1,346 78.56 105.7K 19,818
2011-02-28 Walker Theodore C Officer F-InKind D Common Shares 616 79.30 48.8K 24,947
2011-02-28 Pestcoe Marvin Officer F-InKind D Common Shares 750 79.30 59.5K 14,528
2011-02-28 Clarke Emmanuel Officer F-InKind D Common Shares 582 79.30 46.2K 13,729
2011-02-26 Desmet Laurie Officer D Stock Appreciation Rights 10,200 79.61 812.0K 0
2011-02-18 THIELE PATRICK A Officer S-Sale D Common Shares 250 81.95 20.5K 215,696
2011-02-17 Walker Theodore C Officer A-Award A Common Shares 9,213 0.00 25,563
2011-02-17 THIELE PATRICK A Officer S-Sale D Common Shares 700 81.75 57.2K 219,246
2011-02-17 Pestcoe Marvin Officer A-Award A Common Shares 5,470 0.00 15,278
2011-02-17 Outtrim David Officer A-Award A Common Shares 1,650 0.00 6,050
2011-02-17 Clarke Emmanuel Officer A-Award A Share-Settled Share Appreciation Rights 19,194 81.94 1.57M 19,194
2010-12-27 THIELE PATRICK A Officer S-Sale D Common Shares 100 80.14 8.0K 250,146
2010-12-22 SAUTTER REMY Director M-Exempt D Non-Qualified Share Option (right to buy) 2,000 52.68 105.4K 2,500
2010-12-21 THIELE PATRICK A Officer S-Sale D Common Shares 300 77.57 23.3K 344,001
2010-12-20 THIELE PATRICK A Officer S-Sale D Common Shares 500 78.03 39.0K 356,376
2010-12-02 ROLLWAGEN JOHN A Director M-Exempt D Non-Qualified Share Options 4,000 51.95 207.8K 0

Executive team

Top executives
EBIT / Employee
-126.2K
Shares Outstanding
17.00M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-28 4
2026-05-28 3/A
2026-05-20 6-K
2026-05-20 4
2026-05-14 6-K
2026-05-14 6-K
2026-05-07 6-K
2026-05-04 6-K
2026-04-30 20-F
2026-04-22 SC 13G/A

Executive team

NameTitleCompensationGender
Brian J. Rosin Chief Financial Officer male
Chi Hung Tzang Co-Founder & Chief Scientific Officer
David Eric Vanderveen President of Americas & Executive Director male
Hoi Chun Lo Chief Financial Officer male
James DiNicolantonio Chief Nutrition Officer, Member of Scientific & Medical Advisory Board
Joel Neoh Chief Consumer Officer male
Samantha Kwok Chief of Staff to Group Chief Executive Officer & Vice President of People & Operations female
Senthil Sundaram Chief Clinical Officer
Sheng Wu Yeung Co-Founder, Chairperson & Chief Executive Officer male
ESG Rating
B
MEDICAL - DIAGNOSTICS & RESEARCH
Rank: 13 out of 66
2025
E (Environmental)
64.2 / 61.3
Company / Sector avg.
S (Social)
68.2 / 65.4
Company / Sector avg.
G (Governance)
66.4 / 64.9
Company / Sector avg.
ESG Total
66.3 / 63.8
Company / Sector avg.
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2014-06-19 2014-06-27 Susan M. Collins ME Spouse Sale (Full) $1,001 - $15,000
House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits